Yuhan Corporation (KRX:000100)
115,400
+700 (0.61%)
Apr 18, 2025, 3:30 PM KST
Yuhan Revenue
In the year 2024, Yuhan had annual revenue of 2.07T KRW with 11.23% growth. Yuhan had revenue of 496.10B in the quarter ending December 31, 2024, with 13.49% growth.
Revenue
2,067.79B
Revenue Growth
+11.23%
P/S Ratio
4.18
Revenue / Employee
1.03B
Employees
1,999
Market Cap
8,633.29B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2,067.79B | 208.81B | 11.23% |
Dec 31, 2023 | 1,858.98B | 83.14B | 4.68% |
Dec 31, 2022 | 1,775.85B | 88.04B | 5.22% |
Dec 31, 2021 | 1,687.81B | 67.95B | 4.19% |
Dec 31, 2020 | 1,619.87B | 139.51B | 9.42% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 68.13B |
LigaChem Biosciences | 125.90B |
Peptron | 3.15B |
PharmaResearch | 350.12B |